Unlock instant, AI-driven research and patent intelligence for your innovation.

Recombinant canine long-acting interferon gamma as well as fusion protein preparing long-acting interferon gamma as well as preparation method of fusion protein

A technology of fusion protein and canine interferon, which is applied in the field of biogenetic engineering, can solve the problems of unfavorable clinical application, small molecular weight of interferon, and high cost of interferon, so as to avoid denaturation and renaturation, shorten the time of expression, and improve immunity The effect of answering

Inactive Publication Date: 2018-11-23
WUHU YINGTE FEIER BIOLOGICAL PROD IND RES INST CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The common long-acting interferon on the market is represented by polyethylene glycol fusion interferon, which only partially solves the problem of short half-life due to the small molecular weight of interferon at the molecular weight level. At the same time, the cost of polyethylene glycol fusion interferon is very high. High, not conducive to clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant canine long-acting interferon gamma as well as fusion protein preparing long-acting interferon gamma as well as preparation method of fusion protein
  • Recombinant canine long-acting interferon gamma as well as fusion protein preparing long-acting interferon gamma as well as preparation method of fusion protein
  • Recombinant canine long-acting interferon gamma as well as fusion protein preparing long-acting interferon gamma as well as preparation method of fusion protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] A fusion protein composed of canine interleukin 2 and canine interferon gamma, the preparation method of which is as follows:

[0074] 1. Acquisition and amplification of canine interleukin 2 (IL-2) and canine interferon gamma (IFN-gamma) target genes

[0075] Primer design:

[0076] Design synthetic primers according to the target gene sequence reported in Genebank, see Table 1, introduce BamHI restriction site and Linker sequence into the upstream primer and downstream primer of canine interleukin 2, respectively, and introduce the upstream primer and downstream primer of canine interferon gamma Linker sequence and XhoI restriction site were introduced respectively.

[0077] Table 1PCR amplification primers

[0078]

[0079] RT-PCR to obtain the target gene:

[0080] RNA was extracted from canine liver tissue, and the target genes of IL-2 and IFN-γ were obtained by reverse transcription. The gene sequences of the two are shown in SEQUENCE LISTING 400 and SEQUENC...

Embodiment 2

[0113] A fusion protein composed of canine interleukin 2 and canine interferon gamma, the others are the same as in Example 1, except that the Escherichia coli BL21 (DE3) competent cells are replaced by BL21 (DE3) competent cells with pGro7 plasmid cell. The SDS-PAGE electrophoresis result of the fusion protein is compared with that of Example 1, and the dominant expression band at about 54.7KD in the supernatant is relatively thick, indicating that after the introduction of molecular chaperone pGro7, the expression of the target protein in the supernatant is better, and the obtained The amount of fusion protein is higher. Most of the proteins expressed in E. coli exist in inclusion bodies; by introducing molecular chaperones into the expression strains, the co-expressed proteins can be correctly folded to achieve protein soluble expression.

[0114] The BL21(DE3) competent cells carrying the pGro7 plasmid were purchased from Shanghai Inshore Science & Technology Co., Ltd. / Si...

Embodiment 3

[0116] A fusion protein composed of canine interleukin 2 and canine interferon gamma, the preparation method of which is as follows:

[0117] 1. Acquisition and amplification of canine interleukin 2 (IL-2) and canine interferon gamma (IFN-gamma) target genes

[0118] IL-2 and IFN-γ in Example 1 are optimized, and IL-2 and IFN-γ target genes are artificially synthesized. After optimization, the nucleotide sequences of the two are as SEQUENCE LISTING 400 and SEQUENCE LISTING 400 respectively As shown in .

[0119] 1.1 Codon optimization

[0120] There are 64 genetic codes, but most organisms tend to use a subset of these. Those that are most frequently used are called optimal codons, and those that are not frequently used are called rare or low-usage codons. Virtually every organism commonly used for protein expression or production (including E. coli, yeast, mammalian cells, plant cells, and insect cells) exhibits some degree of difference or bias in codon usage. The expres...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention discloses a recombinant canine long-acting interferon gamma as well as a fusion protein preparing the long-acting interferon gamma as well as a preparation method of the fusion protein.The fusion protein is formed by connecting canine interleukin 2 and canine interferon gamma by virtue of flexible linker, after the fusion protein is mixed with a freeze drying protection agent, the mixture is freeze dried, thus the recombinant canine long-acting interferon gamma is obtained. By adopting the recombinant canine long-acting interferon gamma, the half-life period of the canine interferon gamma can be significantly prolonged and can be increased by 11 times or more compared with the half-life period of the ordinary canine interferon gamma, a broad-spectrum antivirus effect can beachieved, and the immune response of the dog can be improved.

Description

technical field [0001] The invention belongs to the technical field of biogenetic engineering, and specifically relates to a recombinant canine peginterferon gamma, a fusion protein for preparing the peginterferon gamma and a preparation method thereof. Background technique [0002] According to the analysis of the current situation of China's pet industry, the market size of my country's pet industry has reached 105.8 billion yuan by the end of 2014, while China's pet medical industry currently only accounts for about 20%. Compared with the relatively mature US market, the output value of its pet medical The ratio reaches 50%, and there is huge room for development in China's pet medical industry. [0003] Dogs are loyal friends of human beings. With the substantial increase in domestic pet dogs and other dogs, the morbidity and mortality of canine diseases continue to increase, causing both spiritual and economic losses to human beings. The close contact between dogs and h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/70C12N1/21A61P31/12A61P37/04C12R1/19
CPCC07K14/57A61P31/12A61P37/04C07K14/55C07K2319/00C12N15/70C12N2800/22
Inventor 高耀辉鲍可兵徐慕珍赵雨周炜王亚男郭志燕
Owner WUHU YINGTE FEIER BIOLOGICAL PROD IND RES INST CO LTD